By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1455 NW Leary Way

Seattle  Washington  98107  U.S.A.
Phone: 206-285-3500 Fax: 206-285-6619



Digene Corporation 

Company News
Affinivax Announces Collaboration With PATH To Advance The Company’s Lead Vaccine Candidate For Pneumococcal Disease 2/12/2015 10:08:16 AM
Pfenex Inc. (PFNX) And PATH Partner On Vaccines 10/10/2014 9:09:37 AM
Sanofi (France) (SAN.PA), PATH Roll Out First Large-Scale Batches Of Antimalarial Drug 8/12/2014 6:22:18 AM
Novavax, Inc. (NVAX) Announces Continuation Of RSV Vaccine Partnership With PATH 1/13/2014 9:33:15 AM
Advanced BioScience Laboratories, Inc. Selected by PATH to Manufacture Novel Shigella Vaccine Candidate 10/1/2013 10:56:01 AM
Janssen R&D Ireland Announces Agreement With PATH for Early Development of Rilpivirine in Long-Acting Formulation for Potential Prophylactic Intervention 9/25/2013 9:45:58 AM
Liquidia Technologies Inc. Announces Extension of Collaboration With PATH to Develop Next Generation Pneumococcal Vaccine 5/21/2013 9:57:55 AM
PATH Release: Kala-azar Treatment Completes Phase 3(b) Clinical Trial in Bangladesh 12/17/2012 9:42:09 AM
PATH's Drug Development Program Announces Positive Phase 1 Results for Its Anti-Diarrheal Medication 11/12/2012 10:00:59 AM
Novavax, Inc. (NVAX) and PATH Announce Partnership on RSV Vaccine 7/18/2012 9:23:28 AM